微创保组织乳房增大术:大型病例系列的技术与经验
本研究在美国5个中心前瞻性纳入159例接受微创保组织乳房增大术(MI-BA)的女性患者,采用肿胀浸润、95%球囊辅助麻醉技术,58%在局部麻醉加镇静下完成。术后无早期血肿、乳房感觉丧失或异常疼痛,医生满意度96%,患者满意度94%。
要点
- MI-BA利用无创隧道和球囊辅助腔隙创建,可在局部麻醉加镇静下完成。
- 159例患者中13%同期行脂肪移植和/或乳房固定术,无早期血肿或感觉障碍。
- 医生满意度96%,患者满意度或极度满意度94%。
核心结论
- 早期美国经验显示,微创保组织乳房增大术可在局部麻醉下进行,减少软组织创伤并促进快速恢复。
研究设计与样本
- 前瞻性多中心分析,5个手术中心,为期6个月,纳入161例连续患者,排除2例超说明书年龄后分析159例。
主要发现
- 159例女性患者中13%同期行脂肪移植和/或乳房固定术。
- 所有患者接受肿胀浸润,95%采用球囊麻醉技术,58%在局部麻醉加镇静下完成。
- 无早期术后血肿、乳房感觉丧失、感觉障碍或异常疼痛报告。
- 医生满意度96%,患者满意度或极度满意度94%。
关键数值与推荐
- 95%的手术采用球囊麻醉技术,58%在局部麻醉加镇静下完成。
临床怎么用
- 对于适合的患者,MI-BA可作为一种在局部麻醉加镇静下完成的微创乳房增大选择,注重软组织保护。
局限性
- 早期结果良好,但长期随访仍在进行中,将在未来研究中报告。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Breast augmentation rates have remained relatively stagnant due to ongoing concerns regarding implant safety, fear of an oversized aesthetic, and trepidation surrounding general anesthesia. Advances in understanding breast anatomy have enabled innovative techniques that enhance breast volume while preserving surrounding soft tissues. This study presents the initial US experience with a minimally invasive, tissue-preserving breast augmentation (MI-BA) technique utilizing atraumatic tunneling, balloon-assisted pocket creation, and sixth-generation silicone implants. OBJECTIVES: The aim of this study was to describe the authors' early experience with an inframammary-based MI-BA, including its anatomical rationale, surgical technique, learning curve, early outcomes, satisfaction, and practical insights to guide broader adoption. METHODS: A prospective multicenter analysis was performed across 5 surgical centers over a 6-month period. Patient demographics, implant characteristics, anesthesia modality, early complications, patient-reported recovery, and satisfaction scores were prospectively collected. 161 consecutive patients were enrolled across five sites, but 2 were removed from the analysis due to age, as they were implanted off-label. Of note, the 2 patients removed were highly satisfied and had no complications. RESULTS: In total, 159 consecutive female patients underwent MI-BA, with 13% undergoing concomitant fat transfer and/or mastopexy. All patients received tumescent infiltration, 95% of procedures utilized a bolus anesthesia technique, with 58% performed under local anesthesia with sedation. No early postoperative hematomas, loss of breast sensation, sensory disturbances, or abnormal pain were reported. Surgeon satisfaction was high (96%), and most patients reported being satisfied or extremely satisfied (94%). CONCLUSIONS: This early US experience demonstrates a minimally invasive, tissue-preserving approach to breast augmentation that leverages implant-specific technologies to enable procedures under local anesthesia, minimize soft-tissue trauma, and facilitate rapid recovery. Although early outcomes are favorable, continued long-term follow-up is underway and will be reported in future studies. LEVEL OF EVIDENCE: 4 (THERAPEUTIC): For image description, please refer to the figure legend and surrounding text.
引用
- Pittman TA, Steve A, Zeidler K, et al. Minimally Invasive, Tissue-Preserving Breast Augmentation: Insights From a Large Case Series, Technique and Surgical Pearls. Aesthet Surg J. 2026. PMID: 42579316. doi:10.1093/asj/sjag113
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。